International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Response to Sofosbuvir/Ledipasvir for 8 or 12 Weeks in HCV-Monoinfected and HIV/HCV-Coinfected Patients in Clinical Practice | Anaïs Corma

Slideset

HIV

Viral Hepatitis and Liver Disease

Real-life Results of Grazoprevir/Elbasvir in HCV-Infected PWID: The Zepalive Studi | Juan Macías

Slideset

HIV

Viral Hepatitis and Liver Disease

Baseline Resistance-Guided Therapy Does Not Enhance the Response to Interferon-Free Treatment of HCV Infection in Real Life | Luis M. Real

Slideset

HIV

Viral Hepatitis and Liver Disease

HCV care after cure- Raffaele Bruno, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

A Comparison of Single and Multiple Tablet Regiments for the Treatment of HCV Infection Among HIV Co-Infected Individuals | Astou Thiam

Slideset

HIV

Viral Hepatitis and Liver Disease

Long-Term Changes of Liver Stiffness After the Use of All Oral DAA Regimens | Nicolás Merchante

Slideset

HIV

Viral Hepatitis and Liver Disease

Follow-Up of Sustained Virologic Responders with Hepatitis C/HIV Coinfection and Advanced Liver Disease | C. Soeiro

Slideset

HIV

Viral Hepatitis and Liver Disease

HBV managment in HIV patients - Karine Lacombe, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program | Guranda Jikia, MD, MPH

Slideset

HIV

Viral Hepatitis and Liver Disease

HBV Novel Therapies- Maria Buti, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska

Slideset

HIV

Viral Hepatitis and Liver Disease

Epidemiological Characteristics and Factors Contributing to the Development of Liver Fibrosis in HIV/HCV-Coinfected Patients in Ukraine | T. Kyrychenko

Slideset

HIV

Viral Hepatitis and Liver Disease

Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience | C. Valente

Slideset

HIV

Viral Hepatitis and Liver Disease

Debate: TDF vs. TAF in HBV management | Mark Nelson, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Debate: TDF vs. TAF in HBV management | Douglas Dieterich, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Case on HEV- Antonio Rivero-Juarez, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

NAFLD in HIV- infected patients- Juan Macías, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

Failure Rate of Ultrasound Surveillance of Hepatocellular Carcinoma in HIV+ Patients | Nicolás Merchante

Slideset

HIV

Viral Hepatitis and Liver Disease

CD4-T Cell and Metabolic Changes adter DAAs: a Multicenter Study | L.A. Nicolini

Slideset

HIV

Viral Hepatitis and Liver Disease

Expression of Immunological Markers in Inflammatory Infiltrate Cells of Liver in Patients with HIV/HIV Coinfection | N. Matsiyeuskaya

Slideset

HIV

Viral Hepatitis and Liver Disease

Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients | Fábio Videira Santos

Slideset

HIV

Viral Hepatitis and Liver Disease

The role of Fibroscan: pre and post SVR- Nicolás Merchante, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Massimo Puoti, MD

Slideset

HIV

Viral Hepatitis and Liver Disease

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Luz Martin-Carbonero, MD, PhD

Slideset

HIV

Viral Hepatitis and Liver Disease

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

HBV: diagnostics, management and screening- Marion Peters, MD

Liver care in HIV - management of abnormal LFTs- Juan Berenguer, MD, PhD

HCV in 2018- Jürgen Rockstroh, MD

NAFLD: diagnostics, management and screening- Juan Macías, MD, PhD

Fibrosis Markers and Cirrhosis management in HIV patients | Marion Peters, MD

Response to Sofosbuvir/Ledipasvir for 8 or 12 Weeks in HCV-Monoinfected and HIV/HCV-Coinfected Patients in Clinical Practice | Anaïs Corma

Real-life Results of Grazoprevir/Elbasvir in HCV-Infected PWID: The Zepalive Studi | Juan Macías

Baseline Resistance-Guided Therapy Does Not Enhance the Response to Interferon-Free Treatment of HCV Infection in Real Life | Luis M. Real

HCV care after cure- Raffaele Bruno, MD

A Comparison of Single and Multiple Tablet Regiments for the Treatment of HCV Infection Among HIV Co-Infected Individuals | Astou Thiam

Long-Term Changes of Liver Stiffness After the Use of All Oral DAA Regimens | Nicolás Merchante

Follow-Up of Sustained Virologic Responders with Hepatitis C/HIV Coinfection and Advanced Liver Disease | C. Soeiro

HBV managment in HIV patients - Karine Lacombe, MD, PhD

Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program | Guranda Jikia, MD, MPH

HBV Novel Therapies- Maria Buti, MD, PhD

Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017 | Patrycja Machnowska

Epidemiological Characteristics and Factors Contributing to the Development of Liver Fibrosis in HIV/HCV-Coinfected Patients in Ukraine | T. Kyrychenko

Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience | C. Valente

Debate: TDF vs. TAF in HBV management | Mark Nelson, MD

Debate: TDF vs. TAF in HBV management | Douglas Dieterich, MD

Case on HEV- Antonio Rivero-Juarez, PhD

NAFLD in HIV- infected patients- Juan Macías, MD, PhD

Failure Rate of Ultrasound Surveillance of Hepatocellular Carcinoma in HIV+ Patients | Nicolás Merchante

CD4-T Cell and Metabolic Changes adter DAAs: a Multicenter Study | L.A. Nicolini

Expression of Immunological Markers in Inflammatory Infiltrate Cells of Liver in Patients with HIV/HIV Coinfection | N. Matsiyeuskaya

Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients | Fábio Videira Santos

The role of Fibroscan: pre and post SVR- Nicolás Merchante, MD

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Massimo Puoti, MD

Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective- Luz Martin-Carbonero, MD, PhD

HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period | Andrea Lombardi, MD